Form 4: Medtronic Director Kevin E. Lofton Reports Acquisition of Ordinary Shares

Kevin E. Lofton, a director of Medtronic plc, reported the acquisition of 2,165 ordinary shares at $80.86 per share on April 29, 2024, along with dividend reinvestments.

Summary

• On April 29, 2024, Kevin E. Lofton, a Medtronic plc director, acquired 2,165 ordinary shares at a price of $80.86 per share.
• This acquisition was part of a restricted stock unit award that will vest on the one-year anniversary of the award date.
• Lofton also acquired 66 shares through dividend reinvestment since the last report.
• Following the reported transaction, Lofton beneficially owns 6,422 ordinary shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard reporting of stock transactions by a company insider.

Positives

• The acquisition of shares by a director may signal confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates